Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine and sufentanil combinations for prevention of visceral pain after gynecologic laparoscopic surgery
ChiCTR1900025076Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine and sufentanil in postoperative pain (6 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoints: Number of rescue tramadol administrations within 24 hours after surgery and Total rescue tramadol dose within 24 hours after surgery. Started Sep 2019; status: completed.
02
Drugs
nalbuphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1900025076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025076.